Discovery Labs Gets 1 New US Patent, Notices Of Allowance For 2 Patents

(RTTNews) - Discovery Laboratories, Inc. (DSCO) said Wednesday that the United States Patent and Trademark Office has issued a new patent and Notices of Allowance for patents covering critical aspects of its KL4 surfactant and drug delivery technology platform.

The company announced the issuance of U.S. Patent No. 8,701,658 entitled "Ventilation Circuit Adaptor and Proximal Aerosol Delivery System" which provides coverage for our novel disposable aerosol airway connectors which are intended to simplify the delivery of inhaled therapies including aerosolized KL4 surfactant to infants requiring ventilatory support. The patent will expire in April 2029.

Additionally, the company has received Notices of Allowance for two patents, titled "Lyophilization of Synthetic Liposomal Pulmonary Surfactant." The claims of those patents cover composition of matter and methods of manufacturing for lyophilized KL4 surfactant. The patent term of those patents will expire in 2033. The company is initially developing its lyophilized KL4 surfactant for use in its AEROSURF program.